BCAL Diagnostics (ASX:BDX) YoY EPS Growth : 16.67% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. BCAL Diagnostics's YoY EPS Growth for the quarter that ended in Dec. 2023 was 16.67%.

BCAL Diagnostics's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was A$-0.01.

BCAL Diagnostics YoY EPS Growth Historical Data

The historical data trend for BCAL Diagnostics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics YoY EPS Growth Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

YoY EPS Growth

-41.18

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EPS Growth	Get a 7-Day Free Trial			-	-	-100.00	-20.00	16.67

BCAL Diagnostics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

BCAL Diagnostics's YoY EPS Growth for the fiscal year that ended in Jun. 2023 is calculated as:

	YoY EPS Growth (A: Jun. 2023 )
=	(Earnings per Share (Diluted) (A: Jun. 2023 )	-	Earnings per Share (Diluted) (A: Jun. 2022 ))	/	\| Earnings per Share (Diluted) (A: Jun. 2022 ) \|
=	(-0.024	-	-0.017)	/	\| -0.017 \|
=	-41.18 %

BCAL Diagnostics's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (Q: Dec. 2023 )
=	(Earnings per Share (Diluted) (Q: Dec. 2023 )	-	Earnings per Share (Diluted) (Q: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2022 )) \|
=	(-0.01	-	-0.012)	/	\| -0.012 \|
=	16.67 %

BCAL Diagnostics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.